Between August 24 and October 5, 2022, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) completed multiple tranches of a non-brokered private placement of common shares of the company for aggregate proceeds of approximately US$3 million.

IM Cannabis is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers, and is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. 

Gowling WLG advised IM Cannabis with respect to this private placement with a team that included Peter Simeon, Josh Almario, Josh Rosen and Sean Walsh.